UNC Health

     System Formulary Restriction:

     Inpatient use of Avsola injection is restricted to patients who meet one of the following:

• Acute graft-versus-host disease
• Acute steroid-refractory ulcerative colitis or Crohn's disease exacerbation
• Acute steroid-refractory complications of immune-oncology therapy (eg, colitis, hepatitis, nephritis)

     Use of Renflexis injection is restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet one of the following criteria:

• Continuation of therapy in patients who previously received Renflexis
• Initiation of therapy in patients with insurance restrictions that do not cover Avsola

     Use of Remicade injection is restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet one of the following criteria:

• Continuation of therapy in patients who previously received Remicade
• Initiation of therapy in patients with insurance restrictions that do not cover Renflexis or Avsola

UNC Health IV Compendium Guideline

Med Center
     UNC Medical Center Formulary Restrictions

Pardee
     Pardee Therapeutic Interchange

Rex
     Rex Hematology-Oncology Formulary Restrictions

Rockingham
     Therapeutic Interchange Policy

• Lexicomp
• Micromedex
• UpToDate
• FDA Daily Med